PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines.
about
Molecular targeted therapy in advanced renal cell carcinoma: A review of its recent past and a glimpse into the near futureMolecular genetics of clear-cell renal cell carcinomaThe complexes of mammalian target of rapamycin.Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinomaNuclear transport and cancer: from mechanism to intervention.Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndromeInactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancer.Growth, invasion, metastasis, differentiation, angiogenesis and apoptosis of gastric cancer regulated by expression of PTEN encoding products.Biological toxicities as surrogate markers of efficacy in patients treated with mTOR inhibitors for metastatic renal cell carcinoma.Prognostic biomarkers in renal cell carcinoma.mTOR pathway in renal cell carcinoma.Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.Hereditary kidney cancer syndromes.Mammalian target of rapamycin and the kidney. I. The signaling pathway.Metastatic Renal Cancer: What Role for Everolimus?Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma.Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma.PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma.Akt activation in renal cell carcinoma: contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor.Analysis of PTEN gene by fluorescent in situ hybridization in renal cell carcinoma.High levels of Phosphatase and Tensin Homolog Expression Predict Favorable Prognosis in Patients with Non-small Cell Lung Cancer.Loss of tumor suppressor protein PTEN during renal carcinogenesis.
P2860
Q54606041-CB9D398C-22E6-420C-95F6-D4F88F89DE41Q54608371-9EA8FA6A-8779-4BC7-A727-8A10599D1A6CQ54808374-433A01E6-D061-454B-8530-C50F33013B52Q54899602-57AD503D-D553-4B6B-9F28-B6B371616153Q54900760-C8D26E15-0429-4583-BBA6-2D38E522DAB7Q54907017-A0604632-6CE6-4960-B3BC-ED28A5F69D00Q54931069-DFDE4970-4746-47FB-9ACF-7A8F6837B7B5Q54936814-84DDC34D-E118-4A40-B03C-C638BE3C8064Q54936815-39A9D0E6-0366-4604-8F1D-1C7FB2D1E8BDQ54953183-306E2AAD-6140-41E0-8AD7-6FC6B8F89DF0Q54954962-06141A8C-8505-420F-8281-D60B8CD94E62Q54954964-1067E15D-5409-44C5-8A2E-D3FF1231F2A2Q54955018-3AE8F4C8-C675-40C4-87A1-F2E61B28670CQ54993100-C2852260-057E-4344-893E-CD01AD599C48Q54993288-A972A07E-3DC3-49AE-9870-03AA9E26691CQ54993289-4F5ACB66-7875-4B39-B51B-4E583B36F63BQ54995346-23267BC0-FB8D-4059-9378-9DC995615ECD
P1343
Q33599713-92791650-D869-4B57-A16A-C912069A9363Q33729097-144A0CCD-10CB-44C7-A689-084158BDB501Q34116818-1FCCA1C7-3B76-4F83-9229-11E15EB966C2Q35606411-17CB0778-559F-48B5-82F7-4C7EB6D4554CQ35633427-73BD5B9C-447A-4A79-AEA1-143A0CAB1806Q35925866-E1AC93C8-7AB6-4E5B-8269-7A19BB10904EQ36178164-38A528C3-824D-4C03-875C-B4B8BC9039AAQ36178870-A97C7C82-7DFD-4226-9CD9-9ADB0A3F31D8Q36243104-DB45A84A-4D80-488F-B6A1-701915BB4202Q36816038-F80AE039-F02D-4914-9BF4-1757C578BF2FQ37086022-97F6B5C3-7CBD-463B-9DF8-CA320B00E99EQ37401031-2201B585-53F5-431F-90F1-ABB433B5A0E2Q37412363-E243AFA2-2BE1-4AFA-86AC-7E55C9CCBCE8Q37993823-2794F706-B83E-4040-A57B-ADB444169762Q38207580-09EE7E69-61A0-4E49-A234-B99466CBF8FBQ38921200-7A1FF34C-47C3-4D28-A895-D0E1251070BFQ39704965-208B7EA7-FDEB-40FA-9BCE-B48F396D87EAQ39844741-63A7EA1E-D79E-4A2B-BEAC-6E4BA6976CBEQ40409431-9B730FB0-6C27-4BE0-8DEF-940FD910F1FBQ40430804-4DA28E3F-BEDB-4C31-B91D-65A077B16563Q44568144-33A78F22-5CE8-4E11-BC5E-1E22100E996CQ51721747-DFDD3E54-9BCC-4A6E-91FC-70EE93FDEF80Q53390981-E9F8D65B-44E9-4FEC-AD4E-71117FE8642C
P2860
PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
PTEN/MMAC1/TEP1 mutations in h ...... nd renal carcinoma cell lines.
@en
type
label
PTEN/MMAC1/TEP1 mutations in h ...... nd renal carcinoma cell lines.
@en
prefLabel
PTEN/MMAC1/TEP1 mutations in h ...... nd renal carcinoma cell lines.
@en
P2093
P4510
P1476
PTEN/MMAC1/TEP1 mutations in h ...... nd renal carcinoma cell lines.
@en
P2093
K Kobayashi
S Kawakami
P304
P356
10.1002/1097-0215(200002)9999:9999<::AID-IJC1034>3.0.CO;2-S
P577
2001-01-01T00:00:00Z